Antigua and Barbuda vs Trinidad and Tobago: Statin use vs. average non-HDL cholesterol levels
Antigua and Barbuda
3.5
in 2018
Trinidad and Tobago
3.5
in 2018
Antigua and Barbuda rank
52nd
Trinidad and Tobago rank
52nd
Statin use vs. average non-HDL cholesterol levels over time
- Antigua and Barbuda
- Trinidad and Tobago
How they compare
Antigua and Barbuda currently reports 3.5 against 3.5 in Trinidad and Tobago, a difference of 0.
Across all 39 years both countries report, Trinidad and Tobago has been ahead every year.
Antigua and Barbuda ranks 52nd and Trinidad and Tobago ranks 52nd of 191 countries.
Trinidad and Tobago has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.23 | 3.5 | 0.27 | Trinidad and Tobago |
| 1990s | 3.3 | 3.47 | 0.17 | Trinidad and Tobago |
| 2000s | 3.31 | 3.42 | 0.11 | Trinidad and Tobago |
| 2010s | 3.43 | 3.5 | 0.0667 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Antigua and Barbuda or Trinidad and Tobago?
- Antigua and Barbuda, at 3.5 against 3.5 in Trinidad and Tobago as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Antigua and Barbuda and Trinidad and Tobago?
- 0, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Trinidad and Tobago?
- 39 years are reported by both, from 1980 to 2018.
- How do Antigua and Barbuda and Trinidad and Tobago rank globally for statin use vs. average non-hdl cholesterol levels?
- Antigua and Barbuda ranks 52nd and Trinidad and Tobago ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.